Conformational Specificity of Opioid Receptors is Determined by Subcellular Location Irrespective of Agonist

Overview

Journal Elife

Specialty Biology

Date 2021 May 20

PMID 34013886

Citations 14

Authors

Stephanie E Crilly

Wooree Ko

Zara Y Weinberg

Manojkumar A Puthenveedu

Affiliations

Soon will be listed here.

Abstract

The prevailing model for the variety in drug responses is that different drugs stabilize distinct active states of their G protein-coupled receptor (GPCR) targets, allowing coupling to different effectors. However, whether the same ligand generates different GPCR active states based on the immediate environment of receptors is not known. Here we address this question using spatially resolved imaging of conformational biosensors that read out distinct active conformations of the δ-opioid receptor (DOR), a physiologically relevant GPCR localized to Golgi and the surface in neuronal cells. We have shown that Golgi and surface pools of DOR both inhibit cAMP, but engage distinct conformational biosensors in response to the same ligand in rat neuroendocrine cells. Further, DOR recruits arrestins on the surface but not on the Golgi. Our results suggest that the local environment determines the active states of receptors for any given drug, allowing GPCRs to couple to different effectors at different subcellular locations.

Citing Articles

-designed minibinders expand the synthetic biology sensing repertoire.

Weinberg Z, Soliman S, Kim M, Shah D, Chen I, Ott M bioRxiv. 2024; .

PMID: 38293112 PMC: 10827046. DOI: 10.1101/2024.01.12.575267.

Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics.

Sadee W Molecules. 2023; 28(17).

PMID: 37687205 PMC: 10489045. DOI: 10.3390/molecules28176375.

Subcellular location defines GPCR signal transduction.

Radoux-Mergault A, Oberhauser L, Aureli S, Gervasio F, Stoeber M Sci Adv. 2023; 9(16):eadf6059.

PMID: 37075112 PMC: 10115417. DOI: 10.1126/sciadv.adf6059.

Vesicle-associated membrane protein 2 is a cargo-selective v-SNARE for a subset of GPCRs.

Chen H, Weinberg Z, Kumar G, Puthenveedu M J Cell Biol. 2023; 222(7).

PMID: 37022307 PMC: 10082327. DOI: 10.1083/jcb.202207070.

Compartment-Specific Activation of the Proton-Sensor GPR65 is Uncoupled from Receptor Trafficking.

Morales Rodriguez L, Crilly S, Rowe J, Isom D, Puthenveedu M bioRxiv. 2023; .

PMID: 36993269 PMC: 10055196. DOI: 10.1101/2023.03.18.533272.

References

Shiwarski D, Tipton A, Giraldo M, Schmidt B, Gold M, Pradhan A . A PTEN-Regulated Checkpoint Controls Surface Delivery of δ Opioid Receptors. J Neurosci. 2017; 37(14):3741-3752. PMC: 5394893. DOI: 10.1523/JNEUROSCI.2923-16.2017. View

Wingler L, Skiba M, McMahon C, Staus D, Kleinhenz A, Suomivuori C . Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR. Science. 2020; 367(6480):888-892. PMC: 7171558. DOI: 10.1126/science.aay9813. View

Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T . Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9(7):676-82. PMC: 3855844. DOI: 10.1038/nmeth.2019. View

Hooper G, Dick D . Nonuniform distribution of sodium in the rat hepatocyte. J Gen Physiol. 1976; 67(4):469-74. PMC: 2214917. DOI: 10.1085/jgp.67.4.469. View

Dawaliby R, Trubbia C, Delporte C, Masureel M, Van Antwerpen P, Kobilka B . Allosteric regulation of G protein-coupled receptor activity by phospholipids. Nat Chem Biol. 2015; 12(1):35-9. PMC: 4718399. DOI: 10.1038/nchembio.1960. View

Livingston K, Mahoney J, Manglik A, Sunahara R, Traynor J . Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor. Elife. 2018; 7. PMC: 6042960. DOI: 10.7554/eLife.32499. View

Gaidarov I, Krupnick J, Falck J, Benovic J, Keen J . Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO J. 1999; 18(4):871-81. PMC: 1171180. DOI: 10.1093/emboj/18.4.871. View

Mittal N, Roberts K, Pal K, Bentolila L, Fultz E, Minasyan A . Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and β-arrestin 1 pathway. Cell Rep. 2013; 5(4):1010-21. PMC: 3870884. DOI: 10.1016/j.celrep.2013.10.015. View

Rueden C, Schindelin J, Hiner M, DeZonia B, Walter A, Arena E . ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017; 18(1):529. PMC: 5708080. DOI: 10.1186/s12859-017-1934-z. View

10.

Degrandmaison J, Abdallah K, Blais V, Genier S, Lalumiere M, Bergeron F . In vivo mapping of a GPCR interactome using knockin mice. Proc Natl Acad Sci U S A. 2020; 117(23):13105-13116. PMC: 7293596. DOI: 10.1073/pnas.1917906117. View

11.

Nygaard R, Zou Y, Dror R, Mildorf T, Arlow D, Manglik A . The dynamic process of β(2)-adrenergic receptor activation. Cell. 2013; 152(3):532-42. PMC: 3586676. DOI: 10.1016/j.cell.2013.01.008. View

12.

Ikonen E . Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008; 9(2):125-38. DOI: 10.1038/nrm2336. View

13.

McDonald P, Chow C, Miller W, Laporte S, Field M, Lin F . Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 2000; 290(5496):1574-7. DOI: 10.1126/science.290.5496.1574. View

14.

Peterson Y, Luttrell L . The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling. Pharmacol Rev. 2017; 69(3):256-297. PMC: 5482185. DOI: 10.1124/pr.116.013367. View

15.

Stoeber M, Jullie D, Li J, Chakraborty S, Majumdar S, Lambert N . Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells. Elife. 2020; 9. PMC: 7041944. DOI: 10.7554/eLife.54208. View

16.

Nash C, Wei W, Irannejad R, Smrcka A . Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCε to regulate cardiac hypertrophy. Elife. 2019; 8. PMC: 6726460. DOI: 10.7554/eLife.48167. View

17.

Nehme R, Carpenter B, Singhal A, Strege A, Edwards P, White C . Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS One. 2017; 12(4):e0175642. PMC: 5398546. DOI: 10.1371/journal.pone.0175642. View

18.

Cahill C, Morinville A, Lee M, Vincent J, Collier B, Beaudet A . Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci. 2001; 21(19):7598-607. PMC: 6762923. View

19.

Miesenbock G, De Angelis D, Rothman J . Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature. 1998; 394(6689):192-5. DOI: 10.1038/28190. View

20.

Virk M, Williams J . Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization. Mol Pharmacol. 2008; 73(4):1301-8. PMC: 3640555. DOI: 10.1124/mol.107.042952. View